Healthy Inc > Blog > generic Buscopan supplier
Posted on:

What is the use of hyoscine butylbromide injection?

Pharmaceutical Product Monograph: Hyoscine Butylbromide Injection (20 mg/mL)

In the pharmaceutical industry, Hyoscine Butylbromide (also known as Scopolamine Butylbromide) is a quaternary ammonium Antispasmodic and Antimuscarinic agent. As a pharmacist and manufacturer, I view this molecule as a “Smooth Muscle Relaxant”—it is technically designed to block the action of acetylcholine at the parasympathetic nerve endings, specifically targeting the digestive, biliary, and urinary tracts.

At your WHO-GMP facility in Mumbai, Hyoscine Butylbromide 20 mg/mL is a high-demand SKU for Gastroenterology, Urology, and Palliative Care portfolios. Unlike the parent compound (Hyoscine), the butylbromide derivative does not cross the blood-brain barrier, making it much safer for peripheral use without central sedation.

Therapeutic Profile: Primary Indications

Hyoscine Butylbromide injection is indicated for the rapid relief of severe spasms in the smooth muscles of the abdominal and pelvic organs.

IndicationClinical ContextTechnical Rationale
Acute GI SpasmsSevere Colic / GastritisGold Standard: Rapidly relaxes the smooth muscle of the stomach and intestines to stop intense cramping.
Biliary ColicGallstonesRelaxes the bile ducts to allow for easier passage of stones or to reduce the pain of obstruction.
Renal ColicKidney StonesUsed as an adjunct to NSAIDs to relax the ureter and reduce the intensity of “wave-like” pain.
Diagnostic ProceduresEndoscopy / RadiologyAdministered to “freeze” the motion of the gut (aperistalsis) during colonoscopies or double-contrast barium meals.
Palliative Care“Death Rattle”Used to reduce the excessive respiratory secretions in terminal patients, improving comfort.

Mechanism: Competitive Muscarinic Antagonism

Hyoscine Butylbromide works by preventing the “cramp signal” from reaching the muscle:

Receptor Blockade: It acts as a competitive antagonist at Muscarinic receptors ($M_3$) located on the smooth muscle cells of the viscera.

Acetylcholine Inhibition: It prevents Acetylcholine (the primary “contract” signal) from binding to these receptors.

Myolytic Effect: This results in the relaxation of the smooth muscle, effectively stopping the spasm and the associated pain.

Quaternary Structure: Technically, the “Butyl” group makes the molecule highly polar. This prevents it from entering the brain, which is why it doesn’t cause the drowsiness or confusion seen with older anticholinergics.

The Pharmacist’s “Technical Warning”

  • The “Glaucoma” Contraindication: As a pharmacist, I must emphasize that this drug is strictly contraindicated in patients with Narrow-Angle Glaucoma, as it can increase intraocular pressure and lead to blindness.

  • Visual Disturbance: Patients should be warned of Accommodation Disorders (blurred vision). They should not drive or operate machinery for several hours after the injection.

  • Cardiac Warning: It can cause Tachycardia (rapid heart rate). Use with extreme caution in patients with heart failure or hyperthyroidism.

  • Urinary Retention: In elderly men with enlarged prostates (BPH), it can trigger acute urinary retention (inability to urinate).

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Sterile Solution” USP: Hyoscine Butylbromide is relatively stable, but it is sensitive to pH changes. On your digital marketplace, highlight your Precision pH Buffering (3.7 to 5.5). This ensures the injection is both stable and causes minimal stinging at the injection site.

  • The “Diagnostic Suite” Market: For international B2B tenders, market your Hyoscine Butylbromide alongside Glucagon or Barium Sulfate. This “Diagnostic Imaging Bundle” is a high-priority procurement item for modern radiology and gastroenterology departments.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Hyoscine Butylbromide 20 mg/mL ampoules to support your registration in international B2B tenders for hospital and emergency care.

Posted on:

Can hyoscine stop stomach pain?

In the pharmaceutical industry, Hyoscine Butylbromide (widely known by the brand name Buscopan) is the primary antimuscarinic used for abdominal relief. As a pharmacist and manufacturer, I view its role as a “Precision Antispasmodic”—unlike general painkillers that block pain signals in the brain, Hyoscine targets the physical source of the pain by relaxing the overactive muscles in the gut.

At your WHO-GMP facility in Mumbai, where you focus on technical precision and exporting, understanding the distinction between “cramp relief” and “pain blocking” is a vital technical value-add for your gastroenterology portfolio.

Therapeutic Profile: How It Stops Pain

Hyoscine Butylbromide is highly effective for specific types of “stomach pain” caused by spasms, but it is not a general analgesic for all abdominal issues.

IndicationEffect of HyoscineTechnical Rationale
Abdominal CrampsHighly EffectiveRelaxes smooth muscle spasms in the stomach and intestines.
IBS SymptomsHighly EffectiveReduces the hypermotility (over-activity) and bloating associated with IBS.
Menstrual PainEffectiveRelaxes uterine smooth muscle contractions (Dysmenorrhea).
Stomach UlcersIneffectiveDoes not treat the underlying acid-induced sore; may mask the pain temporarily.
Biliary/Renal ColicSupportiveRelaxes the bile ducts or ureters to help “pass” stones with less agony.

Mechanism: Muscarinic Acetylcholine Blockade

Hyoscine works by “unplugging” the signals that tell your gut to contract.

Receptor Antagonism: It acts as a competitive antagonist at Muscarinic ($M_3$) receptors located on the smooth muscle cells of the GI tract.

Signal Interruption: It blocks the neurotransmitter Acetylcholine, which is responsible for triggering muscle contractions.

Local Action: As a quaternary ammonium derivative, it is poorly absorbed into the bloodstream ($<1\%$ bioavailability). This is actually a technical advantage—it stays in the gut to work locally while avoiding the brain (it does not cross the Blood-Brain Barrier).

The Pharmacist’s “Technical Warning”

  • The 15-Minute Window: While the tablet takes about 30–60 minutes to reach full effect, many patients report relief starting within 15 minutes as the drug begins interacting with the intestinal lining.

  • The “Hydrobromide” Confusion: Always warn B2B clients and patients not to confuse Hyoscine Butylbromide (for stomach) with Hyoscine Hydrobromide (for motion sickness). The latter crosses into the brain and causes heavy sedation.

  • Contraindications: It must never be used in patients with Glaucoma (it increases eye pressure), Myasthenia Gravis, or a suspected Bowel Obstruction (it stops the movement needed to clear a blockage).

  • Side Effects: Because it blocks “drying” receptors, common effects include dry mouth, blurred vision, and a slightly faster heart rate.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your facility in Mumbai:

  • The “Sugar-Coated” vs. “Film-Coated” Choice: On your digital marketplace, emphasize the Film-Coating of your 10 mg tablets. This protects the bitter API and ensures smooth transit to the stomach without early degradation.

  • Stability for Export: Hyoscine Butylbromide is stable but sensitive to high heat (above 30°C). Utilizing Alu-Alu blister packaging is the industry standard for ensuring a 36-month shelf life in Zone IVb tropical regions.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers to support your firm’s registration in international tenders for gastrointestinal and “Essential Medicine” programs.

Hyoscine Butyl Bromide tablets

Add to cart